Hepatic insulin resistance following chronic activation of the CREB coactivator CRTC2

Journal of Biological Chemistry

Volumn 290, Issue 43, 2015, Pages 25997-26006

  Hogan, Meghan F ^a,b   Ravnskjaer, Kim ^a,c   Matsumura, Shigenobu ^a,d   Huising, Mark O ^a,e   Hull, Rebecca L ^b   Kahn, Steven E ^b   Montminy, Marc ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d KYOTO UNIVERSITY   (Japan)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL ACTIVATION; GENES; GLUCOSE; INSULIN; MAMMALS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; TRANSCRIPTION;

CONSTITUTIVELY ACTIVES; FORKHEAD TRANSCRIPTIONS; GLUCONEOGENIC GENES; GLUCOSE CONCENTRATION; HEPATIC GLUCONEOGENESIS; HEPATIC INSULIN RESISTANCE; INSULIN CONCENTRATIONS; SELECTIVE ACTIVATION;

GENE EXPRESSION;

CARRIER PROTEINS AND BINDING PROTEINS; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUCOSE; INSULIN; PROTEIN CRTC2; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG; CRTC2 PROTEIN, MOUSE; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, MOUSE; GLUCOSE BLOOD LEVEL; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DOWN REGULATION; FATTY LIVER; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HYPERGLYCEMIA; INSULIN RESISTANCE; LIVER; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; METABOLISM; PHOSPHORYLATION;

ANIMALS; BLOOD GLUCOSE; CELLS, CULTURED; DOWN-REGULATION; FORKHEAD BOX PROTEIN O1; FORKHEAD TRANSCRIPTION FACTORS; INSULIN; INSULIN RESISTANCE; LIVER; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84944880405     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.679266     Document Type: Article

References (34)

1. Barthel, A., and Schmoll, D. (2003) Novel concepts in insulin regulation of hepatic gluconeogenesis. Am. J. Physiol. Endocrinol Metab. 285, E685-E692
2. Samuel, V. T., and Shulman, G. I. (2012) Mechanisms for Insulin Resistance: Common Threads and Missing Links. Cell 148, 852-871
3. Saltiel, A. R., and Kahn, C. R. (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414, 799-806
4. Biddinger, S. B., and Kahn, C. R. (2006) FROM MICE TO MEN: Insights into the Insulin Resistance Syndromes. Annu. Rev. Physiol. 68, 123-158
5. Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., Spiegelman, B. M., and Montminy, M. R. (2001) CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413, 179-183
6. Hagiwara, M., Brindle, P. K., Harootunian, A., Armstrong, R., Rivier, J., Vale, W., Tsien, R., and Montminy, M. R. (1993) Coupling of hormonal stimulation and transcription via the cyclic AMP-responsive factor CREB is rate limited by nuclear entry of protein kinase A. Mol. Cell Biol. 13, 4852-4859
7. Chrivia, J. C., Kwok, R. P., Lamb, N., Hagiwara, M., Montminy, M. R., and Goodman, R. H. (1993) Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365, 855-859
8. Screaton, R. A., Conkright, M. D., Katoh, Y., Best, J. L., Canettieri, G., Jeffries, S., Guzman, E., Niessen, S., Yates, J. R., 3rd, Takemori, H., Okamoto, M., and Montminy, M. R. (2004) The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell 119, 61-74
9. Koo, S.-H., Flechner, L., Qi, L., Zhang, X., Screaton, R. A., Jeffries, S., Hedrick, S., Xu, W., Boussouar, F., Brindle, P. K., Takemori, H., and Montminy, M. R. (2005) The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437, 1109-1111
10. Dentin, R., Hedrick, S., Xie, J., Yates, J., 3rd, and Montminy, M. R. (2008) Hepatic Glucose Sensing via the CREB Coactivator CRTC2. Science 319, 1402-1405
11. Wang, X. L., Suzuki, R., Lee, K., Tran, T., Gunton, J. E., Saha, A. K., Patti, M.-E., Goldfine, A. B., Ruderman, N. B., Gonzalez, F. J., and Kahn, C. R. (2009) Ablation of ARNT/HIF1β; in Liver Alters Gluconeogenesis, Lipogenic Gene Expression, and Serum Ketones. Cell Metab. 9, 428-439
12. Wang, Y., Inoue, H., Ravnskjaer, K., Viste, K., Miller, N., Liu, Y., Hedrick, S., Vera, L., and Montminy, M. R. (2010) Targeted disruption of the CREB coactivator Crtc2 increases insulin sensitivity. Proc. Natl. Acad. Sci. U. S. A. 107, 3087-3092
13. Luo, Q., Luo, Q., Viste, K., Viste, K., Urday-Zaa, J. C., Urday-Zaa, J. C., Kumar, G. S., Tsai, W.-W., Talai, A., Mayo, K. E., Montminy, M. R., and Radhakrishnan, I. (2012) Mechanism of CREB recognition and coactivation by the CREB-regulated transcriptional coactivator CRTC2. Proc. Natl. Acad. Sci. U. S. A. 109, 20865-20870
14. Saberi, M., Bjelica, D., Schenk, S., Imamura, T., Bandyopadhyay, G. K., Li, P., Jadhar, V., Vargeese, C., Wang, W., Bowman, K., Zhang, Y., Polisky, B., and Olefsky, J. M. (2009) Novel liver-specific TORC2 siRNA corrects hyperglycemia in rodent models of type 2 diabetes. AJP: Endocrinology and Metabolism. 297, E1137-E1146
15. Le Lay, J., Tuteja, G., White, P., Dhir, R., Ahima, R. S., and Kaestner, K. H. (2009) CRTC2 (TORC2) Contributes to the Transcriptional Response to Fasting in the Liver but Is Not Required for the Maintenance of Glucose Homeostasis. Cell Metab. 10, 55-62
16. Ravnskjaer, K., Hogan, M. F., Lackey, D., Tora, L., Dent, S. Y. R., Olefsky, J. M., and Montminy, M. R. (2013) Glucagon regulates gluconeogenesis through KAT2B- and WDR5-mediated epigenetic effects. J. Clin. Invest. 123, 4318-4328
17. Song, Y., Altarejos, J. Y., Goodarzi, M. O., Inoue, H., Guo, X., Berdeaux, R., Kim, J.-H., Goode, J., Igata, M., Paz, J. C., Hogan, M. F., Singh, P. K., Goebel, N., Vera, L., Miller, N., Cui, J., Jones, M. R., CHARGE Consortium, GIANT Consortium, Chen, Y.-D. I., Taylor, K. D., Hsueh, W. A., Rotter, J. I., and Montminy, M. R. (2010) CRTC3 links catecholamine signalling to energy balance. Nature 468, 933-939
18. Miller, R. A., Chu, Q., Le Lay, J., Scherer, P. E., Ahima, R. S., Kaestner, K. H., Foretz, M., Viollet, B., and Birnbaum, M. J. (2011) Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling. J. Clin. Invest. 121, 2518-2528
19. Lu, M., Wan, M., Leavens, K. F., Chu, Q., Monks, B. R., Fernandez, S., Ahima, R. S., Ueki, K., Kahn, C. R., and Birnbaum, M. J. (2012) Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1. Nat. Med. 18, 388-395
20. van der Meulen, T., Donaldson, C. J., Cáceres, E., Hunter, A. E., Cowing-Zitron, C., Pound, L. D., Adams, M. W., Zembrzycki, A., Grove, K. L., and Huising, M. O. (2015) Urocortin3 mediates somatostatin-dependent negative feedback control of insulin secretion. Nat. Med. 10.1038/nm.3872
21. Dentin, R., Liu, Y., Koo, S.-H., Hedrick, S., Vargas, T., Heredia, J. E., Yates, J. R., 3rd, and Montminy, M. R. (2007) Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Nature 449, 366-369
22. Hull, R. L., Andrikopoulos, S., Verchere, C. B., Vidal, J., Wang, F., Cnop, M., Prigeon, R. L., and Kahn, S. E. (2003) Increased dietary fat promotes islet amyloid formation and β-cell secretory dysfunction in a transgenic mouse model of islet amyloid. Diabetes 52, 372-379
23. Uebi, T., Tamura, M., Horike, N., Hashimoto, Y. K., and Takemori, H. (2010) Phosphorylation of the CREB-specific coactivator TORC2 at Ser307 regulates its intracellular localization in COS-7 cells and in the mouse liver. Am. J. Physiol. Endocrinol Metab. 299, E413-E425
24. Hull, R. L., Kodama, K., Utzschneider, K. M., Carr, D. B., Prigeon, R. L., and Kahn, S. E. (2005) Dietary-fat-induced obesity in mice results in beta cell hyperplasia but not increased insulin release: evidence for specificity of impaired beta cell adaptation. Diabetologia. 48, 1350-1358
25. Alonso, L. C., Yokoe, T., Zhang, P., Scott, D. K., Kim, S. K., O'Donnell, C. P., and Garcia-Ocaña, A. (2007) Glucose Infusion in Mice: A New Model to Induce β-Cell Replication. Diabetes 56, 1792-1801
26. Nielsen, J. H., Svensson, C., Galsgaard, E. D., Møldrup, A., and Billestrup, N. (1999) Beta cell proliferation and growth factors. J. Mol. Med. 77, 62-66
27. Garcia-Ocaña, A., Takane, K. K., Syed, M. A., Philbrick, W. M., Vasavada, R. C., and Stewart, A. F. (2000) Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass, and induces mild hypoglycemia. J. Biol. Chem. 275, 1226-1232
28. Stoffers, D. A., Kieffer, T. J., Hussain, M. A., Drucker, D. J., Bonner-Weir, S., Habener, J. F., and Egan, J. M. (2000) Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes 49, 741-748
29. El Ouaamari, A., Kawamori, D., Dirice, E., Liew, C. W., Shadrach, J. L., Hu, J., Katsuta, H., Hollister-Lock, J., Qian, W.-J., Wagers, A. J., and Kulkarni, R. N. (2013) Liver-Derived Systemic Factors Drive β Cell Hyperplasiain Insulin-Resistant States. Cell Reports 3, 401-410
30. Ryysy, L., Häkkinen, A.-M., Goto, T., Vehkavaara, S., Westerbacka, J., Halavaara, J., and Yki-Järvinen, H. (2000) Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 49, 749-758
31. Seppälä-Lindroos, A., Vehkavaara, S., Häkkinen, A.-M., Goto, T., Westerbacka, J., Sovijärvi, A., Halavaara, J., and Yki-Järvinen, H. (2002) Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J. Clin. Endocrinol. Metab. 87, 3023-3028
32. Qatanani, M., and Lazar, M. A. (2007) Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev. 21, 1443-1455
33. Hardy, O. T., Czech, M. P., and Corvera, S. (2012) What causes the insulin resistance underlying obesity? Curr. Opin. Endocrinol. Diab. Obes. 19, 81-87
34. Nagle, C. A., Klett, E. L., and Coleman, R. A. (2009) Hepatic triacylglycerol accumulation and insulin resistance. J. Lipid Res. 50, S74-S79